1. An innovative plasmacytoid dendritic cell line-based cancer vaccine primes and expands antitumor T-cells in melanoma patients in a first-in-human trial. (1st January 2020) Authors: Charles, Julie; Chaperot, Laurence; Hannani, Dalil; Bruder Costa, Juliana; Templier, Isabelle; Trabelsi, Sabiha; Gil, Hugo; Moisan, Anaick; Persoons, Virginie; Hegelhofer, Harald; Schir, Edith; Quesada, Jean-Louis; Mendoza, Christophe; Aspord, Caroline; Manches, Olivier; Coulie, Pierre G.; Khamma... Journal: Oncoimmunology Issue: Volume 9:Number 1(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. BDCA1+ cDC2s, BDCA2+ pDCs and BDCA3+ cDC1s reveal distinct pathophysiologic features and impact on clinical outcomes in melanoma patients. Issue 11 (24th November 2020) Authors: Sosa Cuevas, Eleonora; Ouaguia, Laurissa; Mouret, Stephane; Charles, Julie; De Fraipont, Florence; Manches, Olivier; Valladeau‐Guilemond, Jenny; Bendriss‐Vermare, Nathalie; Chaperot, Laurence; Aspord, Caroline Journal: Clinical & translational immunology Issue: Volume 9:Issue 11(2020) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Co-delivery of the NKT agonist α-galactosylceramide and tumor antigens to cross-priming dendritic cells breaks tolerance to self-antigens and promotes antitumor responses. (2nd September 2017) Authors: Ghinnagow, Reem; De Meester, Julie; Cruz, Luis Javier; Aspord, Caroline; Corgnac, Stéphanie; Macho-Fernandez, Elodie; Soulard, Daphnée; Fontaine, Josette; Chaperot, Laurence; Charles, Julie; Soncin, Fabrice; Mami-Chouaib, Fathia; Plumas, Joel; Faveeuw, Christelle; Trottein, François Journal: Oncoimmunology Issue: Volume 6:Number 9(2017) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Diversification of circulating and tumor‐infiltrating plasmacytoid DCs towards the P3 (CD80+ PDL1−)‐pDC subset negatively correlated with clinical outcomes in melanoma patients. Issue 5 (3rd May 2022) Authors: Sosa Cuevas, Eleonora; Bendriss‐Vermare, Nathalie; Mouret, Stephane; De Fraipont, Florence; Charles, Julie; Valladeau‐Guilemond, Jenny; Chaperot, Laurence; Aspord, Caroline Journal: Clinical & translational immunology Issue: Volume 11:Issue 5(2022) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Dysfunctional BTN3A together with deregulated immune checkpoints and type I/II IFN dictate defective interplay between pDCs and γδ T cells in melanoma patients, which impacts clinical outcomes. Issue 11 (9th November 2021) Authors: Girard, Pauline; Sosa Cuevas, Eleonora; Ponsard, Benedicte; Mouret, Stephane; Gil, Hugo; Col, Edwige; De Fraipont, Florence; Sturm, Nathalie; Charles, Julie; Manches, Olivier; Chaperot, Laurence; Aspord, Caroline Journal: Clinical & translational immunology Issue: Volume 10:Issue 11(2021) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Exploration of the Lysis Mechanisms of Leukaemic Blasts by Chimaeric T-Cells. (13th June 2010) Authors: Laurin, David; Marin, Virna; Biagi, Ettore; Pizzitola, Irene; Agostoni, Valentina; Gallot, Géraldine; Vié, Henri; Jacob, Marie Christine; Chaperot, Laurence; Aspord, Caroline; Plumas, Joël Other Names: Yang Hanchun Academic Editor. Journal: Journal of biomedicine and biotechnology Issue: Volume 2010(2010) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Hepatitis B virus exploits C‐type lectin receptors to hijack cDC1s, cDC2s and pDCs. Issue 12 (8th December 2020) Authors: Ouaguia, Laurissa; Dufeu‐Duchesne, Tania; Leroy, Vincent; Decaens, Thomas; Reiser, Jean‐Baptiste; Sosa Cuevas, Eleonora; Durantel, David; Valladeau‐Guilemond, Jenny; Bendriss‐Vermare, Nathalie; Chaperot, Laurence; Aspord, Caroline Journal: Clinical & translational immunology Issue: Volume 9:Issue 12(2020) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Immunologic Features of Patients With Advanced Hepatocellular Carcinoma Before and During Sorafenib or Anti-programmed Death-1/Programmed Death-L1 Treatment. Issue 7 (July 2019) Authors: Macek Jilkova, Zuzana; Aspord, Caroline; Kurma, Keerthi; Granon, Anouck; Sengel, Christian; Sturm, Nathalie; Marche, Patrice N.; Decaens, Thomas Journal: Clinical and translational gastroenterology Issue: Volume 10:Issue 7(2019) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. PDCs efficiently process synthetic long peptides to induce functional virus‐ and tumour‐specific T‐cell responses. Issue 10 (25th August 2014) Authors: Aspord, Caroline; Leloup, Claire; Reche, Sabine; Plumas, Joel Journal: European journal of immunology Issue: Volume 44:Issue 10(2014:Oct.) Page Start: 2880 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. The avidity of tumor‐specific T cells amplified by a plasmacytoid dendritic cell‐based assay can predict the clinical evolution of melanoma patients. (21st October 2017) Authors: Charles, Julie; Chaperot, Laurence; Revol, Bruno; Baudin, Marine; Mouret, Stephane; Hamon, Agnes; Leccia, Marie‐Therese; Plumas, Joel; Aspord, Caroline Journal: Pigment cell & melanoma research Issue: Volume 31:Number 1(2018) Page Start: 82 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗